Working… Menu

Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04851132
Recruitment Status : Recruiting
First Posted : April 20, 2021
Last Update Posted : June 22, 2021
Information provided by (Responsible Party):
Zhouguang Hui, M.D., Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : June 2023